日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multi-omics time-series analysis in microbiome research: a systematic review

微生物组研究中的多组学时间序列分析:系统综述

Sherwani, Moiz Khan; Ruuskanen, Matti O; Feldner-Busztin, Dylan; Nisantzis Firbas, Panos; Boza, Gergely; Móréh, Ágnes; Borman, Tuomas; Putu Erawijantari, Pande; Scheuring, István; Gopalakrishnan, Shyam; Lahti, Leo

Osmotic laxatives do not alter dabigatran plasma concentration in healthy volunteers - a randomized, controlled, cross-over trial

渗透性泻药不会改变健康志愿者血浆中达比加群的浓度——一项随机、对照、交叉试验

Weiss-Tessbach, Matthias; Dizdarevic, Al Medina; Kupis, Alexander; Bischof, Thorsten; Firbas, Christa; Quehenberger, Peter; Derhaschnig, Ulla; Frimmel, Max; Jilma, Bernd; Schoergenhofer, Christian

A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results

一项关于rTSST-1变异疫苗安全性和免疫原性的随机、双盲研究:II期结果

Schoergenhofer, Christian; Gelbenegger, Georg; Hasanacevic, Dzenita; Schöner, Léa; Steiner, Margarete M; Firbas, Christa; Buchtele, Nina; Derhaschnig, Ulla; Tanzmann, Andreas; Model, Nina; Larcher-Senn, Julian; Drost, Manuel; Eibl, Martha M; Roetzer, Andreas; Jilma, Bernd

Very low doses of rituximab in autoimmune hemolytic anemia-an open-label, phase II pilot trial

利妥昔单抗极低剂量治疗自身免疫性溶血性贫血——一项开放标签的 II 期试点试验

Moser, Miriam M; Thalhammer, Renate; Sillaber, Christian; Derhaschnig, Ulla; Firbas, Christa; Jäger, Ulrich; Jilma, Bernd; Schoergenhofer, Christian

The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A

血管性血友病因子结合适体rondaptivon pegol可作为治疗重度和非重度A型血友病的药物

Ay, Cihan; Kovacevic, Katarina D; Kraemmer, Daniel; Schoergenhofer, Christian; Gelbenegger, Georg; Firbas, Christa; Quehenberger, Peter; Jilma-Stohlawetz, Petra; Gilbert, James C; Zhu, Shuhao; Beliveau, Martin; Koenig, Franz; Iorio, Alfonso; Jilma, Bernd; Derhaschnig, Ulla; Pabinger, Ingrid

Enriched stable 204Pb as tracer at ultra-low levels in clinical investigations

富集稳定 204Pb 作为超低浓度示踪剂用于临床研究

Johanna Irrgeher, Thomas Berger, Anastassiya Tchaikovsky, Cornelius Tschegg, Ghazaleh Gouya, Peter Lechner, Anika Retzmann, Christine Opper, Christa Firbas, Michael Freissmuth, Kerstin Peschel-Credner, Karolina Anderle, Claudia Meisslitzer, Michael Wolzt, Thomas Prohaska

Dealing with dimensionality: the application of machine learning to multi-omics data

处理维度问题:机器学习在多组学数据中的应用

Feldner-Busztin, Dylan; Firbas Nisantzis, Panos; Edmunds, Shelley Jane; Boza, Gergely; Racimo, Fernando; Gopalakrishnan, Shyam; Limborg, Morten Tønsberg; Lahti, Leo; de Polavieja, Gonzalo G

Multidimensional chromatin profiling of zebrafish pancreas to uncover and investigate disease-relevant enhancers

对斑马鱼胰腺进行多维染色质分析,以发现和研究与疾病相关的增强子

Renata Bordeira-Carriço #, Joana Teixeira #, Marta Duque #, Mafalda Galhardo, Diogo Ribeiro, Rafael D Acemel, Panos N Firbas, Juan J Tena, Ana Eufrásio, Joana Marques, Fábio J Ferreira, Telmo Freitas, Fátima Carneiro, José Luís Goméz-Skarmeta, José Bessa

The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial

血管性血友病因子A-1结构域结合适体BT200可提高血浆中血管性血友病因子和因子VIII的水平:一项首次人体试验

Kovacevic, Katarina D; Grafeneder, Jürgen; Schörgenhofer, Christian; Gelbenegger, Georg; Gager, Gloria; Firbas, Christa; Quehenberger, Peter; Jilma-Stohlawetz, Petra; Bileck, Andrea; Zhu, Shuhao; Gilbert, James C; Beliveau, Martin; Jilma, Bernd; Derhaschnig, Ulla

Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial

单克隆CD38抗体felzartamab治疗晚期抗体介导的肾移植排斥反应的安全性、耐受性和有效性:一项II期试验的研究方案

Mayer, Katharina A; Budde, Klemens; Halloran, Philip F; Doberer, Konstantin; Rostaing, Lionel; Eskandary, Farsad; Christamentl, Anna; Wahrmann, Markus; Regele, Heinz; Schranz, Sabine; Ely, Sarah; Firbas, Christa; Schörgenhofer, Christian; Kainz, Alexander; Loupy, Alexandre; Härtle, Stefan; Boxhammer, Rainer; Jilma, Bernd; Böhmig, Georg A